alexa Development Cooperation: Which Role in Combating Tuberculosis? | Open Access Journals
ISSN: 2161-1068
Mycobacterial Diseases
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Development Cooperation: Which Role in Combating Tuberculosis?

Francesco Di Gennaro1,2 and Damiano Pizzol1*

1Operational Research Unit, Doctors with Africa Cuamm, Beira, Mozambique

2Clinic of Infectious Diseases, University of Bari, Bari, Italy

*Corresponding Author:
Damiano Pizzol
Operational Research Unit, Doctors with Africa CUAMM
Rua Fernao Mendes Pinto 165, Ponta Gea 1363 Beira, Mozambique
Tel: (+39) 3668731237
E-mail: [email protected]

Received date: March 07, 2017; Accepted date: March 23, 2017; Published date: March 28, 2017

Citation: Gennaro FD, Pizzol D (2017) Development Cooperation: Which Role in Combating Tuberculosis?. Mycobact Dis 7:236. doi:10.4172/2161-1068.1000236

Copyright: © 2017 Gennaro FD. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Mycobacterial Diseases

Dear Editor

Despite the years go by, Tuberculosis (TB) remains one of the top ten causes of death worldwide [1]. It has been estimated that in 2015 10.4 million people were diagnosed with TB worldwide, causing 1.8 million deaths. The incidence and mortality rates are significantly higher in low and middle income countries; in particular, over 90% global TB cases and deaths occur in developing countries. [2]. For these reasons, the entire healthcare communities of these countries are devoted to fighting TB, and the cooperation among various healthcare organizations play a key role in the process. The post-2015 global tuberculosis target aims to reduce TB incidence by 90% by 2035 [3]. The WHO urges the developing countries to provide integrated patient-centered care and prevention, bold policies, and supportive systems, research and innovation [3]. We believe these approaches are an effective means to achieve the goals in fighting TB, and healthcare cooperation is essential in driving these changes. But how can these goals are achieved? A rapid social and healthcare acceleration will surely bring forth challenges amongst the poor and socially excluded groups. Thus, many aspects in life, healthcare, economy and diseases are closely interwoven in fighting and eradicating TB [4].

A pharmacological approach alone is unlikely to be sufficient to eradicate TB and synergistic actions are needed. Expanding care, strengthening prevention, and intensifying research will be central of health programs.

Accurate information dissemination and healthcare education play a central role in disease intervention. In low-income countries, heath care has to deal with many socio-cultural aspects as myths, superstitions and traditional healers that turn away patients from conventional medicine. Moreover, people are often reluctant to be to be tested for TB in fear of marginalization.

From a clinical point of view, in low-income countries, there is the highest burden of disease and the lowest health care resource both in in terms of health workers and infrastructures. For an effective and appropriate approach in order to eradicate or, at least contain TB, it is mandatory to improve and increase efforts in terms of early and reliable diagnosis, appropriate management and effective follow-up. In our opinion, these goals can be achieved by joint efforts through cooperation of all healthcare providers in order to increase the number of competent healthcare workers and to standardize the medical procedures. In particular, facilitated diagnosis of TB would be pivotal to fight TB, especially in low income countries where incidence is high and radiological techniques are scarce. Chest ultrasonography (CUS) is becoming an attractive non-invasive medical imaging modality for resource-limited settings, [5] where radiological equipment and expertise are scarce. Chest ultrasound may become a tool for TB diagnosing in low settings and research has a crucial role in developing new diagnostic methods.

In fact, although we face with little research capacity in low-income settings, operational research could play a crucial role in TB fighting. Through a scientific approach we can achieve many results: 1) to assess TB burden, including risk factors, at risk hotspot and associated diseases; 2) to reduce the gap between demand and healthcare delivery, identifying the best strategy and evaluating the effectiveness of intervention; 3) to increase local staff capacity building and, thus, convey appropriate competences and skills.

In conclusion, we think that only a multitasking, dynamic and into the context, development cooperation could have high social, clinical and scientific impacts on prevailing in the fight against TB. The challenge for aid workers will be to immerse themselves in the context, gain the trust of healthcare workers and local authorities and pass on their knowledge adapting to the environment without losing quality. Only in this way could we ensure a sustainable, lasting and high impact intervention for the people, the centre of our works, actions and dreams.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 362
  • [From(publication date):
    March-2017 - Sep 23, 2017]
  • Breakdown by view type
  • HTML page views : 311
  • PDF downloads :51
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords